Citus Suspension Tablet 140mg (Franlucast Hydrate)

Child dose

Children: Administer 7 mg/kg/day of pranlukast hydrate orally in 2 divided doses after breakfast and dinner. Do not swallow or divide this medicine. Dissolve it in a small amount of water before taking. Put a small amount of water in a spoon, add 1 tablet of this medicine, and wait for the tablet to disintegrate. Stir before taking and take promptly. The maximum daily dose of this medicine is 10 mg/kg; do not exceed 450 mg daily. The standard dose per administration by body weight is as follows. Administer twice daily after breakfast and dinner. 12 kg or more and less than 18 kg: 1 50 mg dispersible tablet (50 mg of pranlukast hydrate) 18 kg or more and less than 25 kg: 1 70 mg dispersible tablet (70 mg of pranlukast hydrate) 25 kg or more and less than 35 kg: 1 100 mg dispersible tablet (100 mg of pranlukast hydrate) 35 kg or more and less than 45 kg: 1 140 mg dispersible tablet (140 mg of pranlukast hydrate)

This medication contains the artificial sweetener aspartame and should not be used in patients with the genetic disease known as phenylketonuria. Care should be taken not to exceed the daily allowable amount of aspartame, especially for adults weighing 60kg, as the maximum daily dosage should be adhered to. Patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication due to the lactose included. Serious allergic reactions such as shock or anaphylaxis may occur during use; therefore, if symptoms such as hypotension, altered consciousness, dyspnea, or rash occur, the medication should be stopped immediately and medical assistance should be sought. Blood abnormalities such as leukopenia or thrombocytopenia may occur, so if symptoms like fever, sore throat, general malaise, purpura, epistaxis, or bleeding occur, consult a physician. Symptoms of liver dysfunction such as jaundice or elevated liver enzymes may appear, so liver health should be periodically monitored. Interstitial pneumonia or eosinophilic pneumonia may occur due to respiratory issues; therefore, if symptoms such as cough, dyspnea, or fever are present, notify medical personnel immediately. If musculoskeletal symptoms such as myalgia, weakness, or elevated muscle enzyme levels occur, the drug should be discontinued and medical advice should be sought. If hypersensitivity reactions such as rashes, urticaria, or itching occur, discontinue use immediately and seek appropriate treatment. Neuropsychiatric symptoms such as insomnia, paresthesia, tremors, anxiety, taste disturbances, headaches, and dizziness may occur, so monitor the patient's condition closely. Gastrointestinal symptoms such as upper abdominal discomfort, loss of appetite, nausea, vomiting, diarrhea, abdominal pain, constipation, and loss of appetite may occur, and if symptoms persist, consult a physician. Cardiovascular symptoms such as arrhythmias, palpitations, and flushing may occur, so they should be monitored. Urinary symptoms such as decreased urine output, frequent urination, and dysuria may occur, so seek medical attention if discomfort persists. While taking this medication, it will not alleviate acute asthma attacks unlike bronchodilators or steroids, therefore, appropriate treatment should be administered simultaneously in case of asthma deterioration. Patients receiving steroid treatment should reduce their steroid dosage gradually when taking this medication, and sudden discontinuation should be avoided. Serious side effects such as vasculitis have been reported with the use of leukotriene antagonists, so watch for symptoms of vasculitis carefully. Mental symptoms such as depression, suicidal thoughts, and aggressive behavior have been reported, so closely observe the patient's mental state after administration. If the drug proves ineffective, caution should be exercised to avoid prolonged use, especially in children, as they may have difficulty expressing their symptoms, necessitating careful observation by the caregiver. This drug is primarily metabolized in the liver, so caution is needed when taken with other medications that may affect liver metabolism as it could alter drug concentrations. Pregnant women or women of childbearing age should only use this medication with caution when necessary. Safety has not been established for infants under 1 year, newborns, or low birth weight infants, so it's best to avoid use. Elderly patients may have decreased bodily functions, so reducing the dosage is advisable.

• Shock
• anaphylaxis-like symptoms
• hypotension
• altered consciousness
• dyspnea
• rash
• leukopenia
• fever
• sore throat
• generalized malaise

This medication should be stored in a tightly sealed container to protect it from air and moisture exposure. It is best kept at room temperature between 1 and 30 degrees Celsius.

Appearance

White to pale yellow heart-shaped suspension tablet

Package unit

60 tablets (6 tablets/Alu-Alu x 10)